IRONMAN LABS · 30 mg
Reta
Triple-agonist research compound
A next-generation research peptide studied for its multi-receptor activity in metabolic research settings.
$145
Lab Verified
Lab Tested
Discreet Ship
Research Information
Retatrutide is investigated in preclinical research for its interactions with GLP-1, GIP, and glucagon receptor pathways.
For research purposes only. Not for human consumption.
Specifications
- Form
- Lyophilized powder
- Storage
- 2–8°C, protect from light
Related products
